Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Shimon Slavin (
The Center for Innovative Cancer Immunotherapy & Cellular Medicine Weizmann Center, Israel

Shimon Slavin, MD, Professor of Medicine, pioneered the use of personalized anti-cancer immunotherapy mediated by donor lymphocytes and innovative methods for stem cell transplantation for cure of malignant and life-threatening non-malignant disorders, including treatment of autoimmune diseases and induction of transplantation tolerance to bone marrow and organ allografts. More recently, Slavin pioneered the use of multi-potent mesenchymal stromal cells for multi-system regenerative medicine. Slavin authors 4 books, >660 scientific publications and serves on many editorial boards and many national and international advisory boards. Slavin received many international awards in recognition of his contributions for treatment of cancer and non-malignant disorders.


Abstract In sharp contrast to existing immunotherapy procedures based on activation of patient’s own immune system, our working hypothesis was that optimal induction of immunotherapy may be accomplished using intentionally mismatched activated donor lymphocytes as the most effective approach for elimination of fully resistant malignant cells by a mechanism resembling rejection of an allograft. Using murine B cell leukemia (BCL1) and based on their pilot clinical experience, they proved that effective graft-vs-leukemia (GVL) effects following SCT and durable engraftment of donor lymphocytes could eliminate otherwise incurable heavy tumor burden but at the risk of severe GVHD. Accordingly, they developed an immunotherapy protocol based on the use of non-engrafting, Intentionally mismatched activated Killers (IMAK) activated in vitro for five days with IL-2 prior to cell infusion with five days activation in vivo following cell infusion with no prior SCT. They confirmed that curative GVL was induced by IMAK with no risk of GVHD due to consistent rejection of mismatched donor lymphocytes treated at the stage of minimal residual disease (MRD), elimination of leukemia and cure were accomplished by transient circulation of alloreactive donor lymphocytes consisting of T & NK cells combined, indicating that “the last” cancer cell was eliminated since even residual of 10 BCL1 cells can result in lethal leukemia. Using IMAK following non-myeloablative conditioning in parallel with suppression of regulatory T cells by cyclophosphamide and using alpha interferon for induced expression of cancer antigens, their first multiple myeloma patients as well as our first patient with AML and two with NHL remain disease free >25 years. Long-term progression-free survival was also reported in other patients with hematologic malignancies and even solid tumors since then but cure of cancer by IMAK depends exclusively on clinical application of successful immunotherapy at the stage of minimal residual disease.

Speaker Presentations

Speaker Presentations

Speaker PDFs

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
Exhibitor | Sponsorship | Partnering
WhatsApp Queries
More details about

Terms and Conditions


The organizers hold no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, loss, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.



No insurance, of any kind, is included along with the registration in any of the events of the organization.



Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.



Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.


Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact to request a personalized letter of invitation, if not received until one month before the scheduled date of the event.

All the bank charges applicable during refund will be deducted from the account of participant.


Cancellation Policy

All cancellations or modifications of registration must be made in writing to

If due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Postponement of event 

If due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

·   Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.

·         Within 60-30 days of Conference: Eligible for 50% of payment Refund

·         Within 30 days of Conference: Not eligible for Refund

·         E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness of the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.